Epithalon vs SS-31

Epithalon and SS-31 are both tetrapeptides supplied at 10mg. Every visible specification matches. They have almost nothing else in common, and the fact that the spec sheet cannot distinguish them is the most useful thing about this comparison.

Proxiva Handling & Storage DeskReconstitution, stability and laboratory practice

Everything the specification tells you, and why it is not enough

Put the two spec sheets side by side. Nothing distinguishes them.

The first five rows match. Exactly. The last two do not, and they decide everything.

Do not reason from the top five rows. That is the trap this page exists to flag.

A spec sheet describes packaging. Chain length. Fill weight. Physical form. Storage temperature. All real. None of them describes behaviour.

Two molecules can match on every printed field and share no biology at all. These two do exactly that.

Never assume a claim about one transfers to the other. It does not. The paperwork gives you no basis for the assumption, and the paperwork is all most buyers ever see.

What makes SS-31 different

The distinguishing feature is structural and it concerns where the molecule ends up.

SS-31 carries an alternating pattern of aromatic and basic residues that gives it a particular charge distribution. That distribution causes it to concentrate at the inner mitochondrial membrane rather than distributing without preference. The peptide accumulates where it acts.

This is a genuinely unusual property. Most short peptides have no comparable mechanism, and achieving subcellular localisation without a dedicated delivery system is difficult. Whatever else is or is not established about the compound, the targeting is a real structural feature rather than a claim about outcomes.

It also has a practical consequence worth noting: targeting is a property of sequence and charge, so it cannot be conferred by quantity, formulation or intent. No amount of a non-targeted peptide acquires this distribution, which is why the two compounds here are not substitutable in either direction.

This sets SS-31 apart from MOTS-c too, which is also discussed in a mitochondrial context but through a different route entirely — MOTS-c is encoded within mitochondrial DNA, which is a statement about origin rather than about where an administered molecule concentrates. The two are frequently conflated and the distinction is worth holding.

What Epithalon is, and the caution that attaches

Epithalon is a four-residue sequence with an unusual provenance. It emerged from a research programme concerned with pineal preparations. Much of that work was conducted in one research tradition and published in one language.

The result is a familiar difficulty. Selank and Semax present it too. The work may be perfectly sound. Assessing it at second hand is the obstacle.

English descriptions cite each other. They do not cite the studies. A claim can circulate very widely and rest on very little.

One caution is specific to this compound. Its associated claims are unusually far-reaching relative to the evidence available to check them. That combination warrants more scrutiny, not less.

Apply a genealogical test. Follow the claim backwards. Count the steps to a measurement. One or two steps is worth weighing. A chain of summaries is not, however often it repeats.

This establishes nothing about whether the compound works. It establishes that the confident tone of most writing about it exceeds what can currently be checked. Those are different statements. Do not conflate them.

Verification: what four residues does and does not simplify

Short chains are easy to make. Both benefit. Do not mistake that for safety.

Four residues means three couplings. Little can go wrong mid-chain. The deletion sequences that plague long peptides are largely absent here.

So stop looking for them. Look elsewhere.

On a short peptide the real failures are blunt. Wrong molecule. Or the right molecule, short-filled.

Confirm identity by mass spectrometry. Then confirm fill weight separately. Never infer quantity from a purity figure — purity is a ratio and says nothing about mass in the vial.

Read the trace anyway. Not for adjacent peaks. For evidence that anyone ran the analysis at all. A generated document and a real one look different once the chromatogram is open.

One more warning applies to both. Neither compound has a widely circulated reference standard. That puts the weight on whoever did the testing. Treat a certificate from the synthesis facility alone as the weakest form available, and ask for independent work.

Check one further thing before you order either. Confirm the vendor states which of the two you are buying in unambiguous terms.

This sounds trivial. It is not. Both compounds circulate under multiple designations — code numbers, sequence abbreviations, and trade-style names that vary by supplier — and the naming is not standardised across the market.

Match the name against the sequence, not against the marketing. A four-residue peptide has a short and checkable sequence. Ask for it. A vendor who cannot supply it on request has told you something useful.

Handling

Both keep well as dry powder under refrigeration and both deteriorate considerably faster in solution. Where a vial will be opened more than once, bacteriostatic water is the appropriate choice; unpreserved sterile water suits a single withdrawal and nothing beyond it.

Run the liquid down the glass rather than pouring it onto the cake, and let dissolution happen instead of driving it. Neither of these molecules gains anything from being shaken.

Cycling a vial in and out of the cold repeatedly does more harm than one heavy-handed reconstitution, and it is the harder failure to catch precisely because each individual instance looks harmless.

There is a difficulty peculiar to small fills that deserves mention here. At 10mg in a small vial, whatever clings to the glass and stopper represents a much larger share of the total than the same residue would in a large fill. Under-recovery is therefore a real and systematic loss rather than a rounding error, and it argues for reconstituting deliberately and recovering with care rather than quickly.

Two further habits are worth building, and neither costs anything.

Photograph the vial and its label on arrival. Do it before opening. A dispute about what was supplied is unwinnable once the seal is broken and the powder is gone.

Log the reconstitution date on the vial itself. Memory fails across a programme of any length, and an uncertain date turns usable material into material that cannot be relied upon.

Neither habit improves the compound. Both protect the work around it, which fails far more often than the chemistry does.

What has not been established for either

No study has compared these two, and there is no shared endpoint on which both have been measured. Any ranking has been constructed rather than found.

Both literatures are limited, and they are weak in different ways, which is worth separating. Epithalon's difficulty is access: the primary work is hard to check directly and secondary accounts recirculate. SS-31's is maturity: the work is accessible and conducted under familiar conventions, but the compound is comparatively recent and the ordinary process of challenge and replication has not run its course.

One is hard to verify at second hand. The other is straightforward to read and has not yet been tested by time. Neither of those is the same as being well supported, and confusing either with adequacy is the most common error in writing about both.

Nor has any combination been examined. The two appear together because their specification sheets look alike, which is exactly the reasoning this comparison exists to dismantle.

Frequently asked questions

Research use only. All products referenced on this page are sold strictly for laboratory and research purposes. They are not drugs, foods, cosmetics, or medical devices, and they are not intended to diagnose, treat, cure, or prevent any disease. They are not for human or veterinary consumption. Handling should be performed only by qualified individuals in an appropriate laboratory setting.